详情页 - 首都医科大学附属北京同仁医院知识库

当前位置：首页 > 详情页

Prevalence of recommended anticoagulation by guidelines preadmission and its impact on the incidence of acute myocardial infarction (AMI) and in-hospital outcomes after AMI in atrial fibrillation patients.

9| 认领 | 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

机构： [1]Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, No.1, Dong Jiao Min Xiang Street, Dongcheng District, Beijing 100730, China [2]Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China [3]Emergency Department of China-Japan Friendship Hospital, No. 2 YinghuaDongjie, Hepingli, Chaoyang District, Beijing 100029, China [4]Trauma Center, Peking University People’s Hospital, Beijing 100044, China [5]Department of Ultrasound, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China

出处：

DOI：

ISSN：

关键词： Atrial fibrillation Recommended coagulation Acute myocardial infarction All-cause death

摘要：

This study was designed to explore the prevalence of recommended anticoagulation by guidelines before admission and its impact on the incidence of acute myocardial infarction (AMI) and the AMI associated in-hospital outcomes in patients with atrial fibrillation (AF). 10,725 patients with AF at their first hospitalizations in our hospitals were retrospectively reviewed, with a prevalence of recommended anticoagulation preadmission 24.41% (Number = 2618). They had lower risk of AMI incidence (Adjusted OR 0.66, 95%CI 0.54-0.81, p < 0.001) compared to those without recommended anticoagulation after multivariate logistic regression. Furthermore, recommended anticoagulation preadmission reduced in-hospital all-cause death associated with AMI in univariate logistic analysis, but had no impact on the risk of in-hospital bleeding and stroke after AMI both in univariate and multivariate logistic analysis. The prevalence of recommended anticoagulation before admission was 24.41% in China. Recommended anticoagulation reduced incidence of hospitalized AMI, but had no impact on the associated in-hospital bleeding and stroke risk after AMI.© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

基金：

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2021]版：

大类 | 4 区医学

小类 | 4 区心脏和心血管系统 4 区血液学 4 区外周血管病

最新[2025]版：

大类 | 3 区医学

小类 | 3 区血液学 4 区心脏和心血管系统 4 区外周血管病

JCR分区：

出版当年[2020]版：

Q3 PERIPHERAL VASCULAR DISEASE Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Q4 HEMATOLOGY

最新[2024]版：

Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Q3 HEMATOLOGY Q3 PERIPHERAL VASCULAR DISEASE

影响因子： 2.2 最新[2024版] 2.2 最新五年平均 2.3 出版当年[2020版] 2.68 出版当年五年平均 2.054 出版前一年[2019版] 5.221 出版后一年[2021版]

第一作者：

第一作者机构： [1]Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, No.1, Dong Jiao Min Xiang Street, Dongcheng District, Beijing 100730, China

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

Prevalence of recommended anticoagulation by guidelines preadmission and its impact on the incidence of acute myocardial infarction (AMI) and in-hospital outcomes after AMI in atrial fibrillation patients.

文献详情

相关文献